219 related articles for article (PubMed ID: 24205724)
1. [Features of hypertriglyceridemia in chronic kidney disease(CKD)].
Saito T
Nihon Rinsho; 2013 Sep; 71(9):1618-22. PubMed ID: 24205724
[TBL] [Abstract][Full Text] [Related]
2. Lipid disorders and their relevance to outcomes in chronic kidney disease.
Vaziri ND; Norris K
Blood Purif; 2011; 31(1-3):189-96. PubMed ID: 21228589
[TBL] [Abstract][Full Text] [Related]
3. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
4. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
Ćwiklińska A; Cackowska M; Wieczorek E; Król E; Kowalski R; Kuchta A; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Zielińska J; Dębska-Ślizień A; Jankowski M
Kidney Blood Press Res; 2018; 43(3):970-978. PubMed ID: 29913451
[TBL] [Abstract][Full Text] [Related]
5. Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid-rich fish oil suppresses postprandial hypertriglyceridemia.
Ikeda I; Kumamaru J; Nakatani N; Sakono M; Murota I; Imaizumi K
J Nutr; 2001 Apr; 131(4):1159-64. PubMed ID: 11285319
[TBL] [Abstract][Full Text] [Related]
6. [Acquired hypertriglyceridemia].
Takahashi M; Ishibashi S
Nihon Rinsho; 2013 Sep; 71(9):1597-601. PubMed ID: 24205720
[TBL] [Abstract][Full Text] [Related]
7. [Physiology and pathophysiology of the metabolism of lipoproteins].
Sandhofer F
Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
Gotto AM
Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
[TBL] [Abstract][Full Text] [Related]
10. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
[TBL] [Abstract][Full Text] [Related]
11. Selective deficiency of hepatic triglyceride lipase in uremic patients.
Mordasini R; Frey F; Flury W; Klose G; Greten H
N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
[TBL] [Abstract][Full Text] [Related]
12. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
Berg G; Halperín H; Siseles N; Wikinski R
Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein metabolism.
Beisiegel U
Eur Heart J; 1998 Feb; 19 Suppl A():A20-3. PubMed ID: 9519338
[TBL] [Abstract][Full Text] [Related]
14. [Lipoproteins, post-heparin lipoprotein lipase and hepatic triglyceride lipase in patients with and without severe hyperlipemia caused by alcoholism].
Breier C; Lisch HJ; Braunsteiner H
Acta Med Austriaca; 1985; 12(1):25-9. PubMed ID: 4013622
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C beta-interferon-induced severe hypertriglyceridaemia with apolipoprotein E phenotype E3/2.
Homma Y; Kawazoe K; Ito T; Ide H; Takahashi H; Ueno F; Matsuzaki S
Int J Clin Pract; 2000 May; 54(4):212-6. PubMed ID: 10912307
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
[TBL] [Abstract][Full Text] [Related]
17. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
[TBL] [Abstract][Full Text] [Related]
18. [Lipid metabolism abnormalities in Chronic Kidney Disease].
Bianchi S; Baronti A; Cominotto R; Bigazzi R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010
[TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein lipase. Interest in clinical biochemistry (author's transl)].
Etienne J; Debray J
Pathol Biol (Paris); 1980 Mar; 28(3):193-6. PubMed ID: 6988774
[TBL] [Abstract][Full Text] [Related]
20. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
